Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06084806

Test-retest Evaluation of [18F]F-AraG PET

Led by CellSight Technologies, Inc. · Updated on 2024-10-24

10

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

C

CellSight Technologies, Inc.

Lead Sponsor

U

University of Iowa

Collaborating Sponsor

AI-Summary

What this Trial Is About

This pilot study aims to evaluate the test-retest variability of \[18F\]F-AraG-PET imaging in patients with advanced NSCLC tumors. The main objectives of the study are to quantify the uptake of \[18F\]F-AraG in tumors and lymphoid tissue in two consecutive scans spaced not longer than 7 days apart from each other to estimate the magnitude of physiologic and measurement variability. To explore these objectives, eligible subjects will undergo two \[18F\]F-AraG PET/CT scans within 7 days of each other prior to receiving treatment. This study is a single-site, open-label, non-randomized, single-arm pilot trial. Patients and care providers will not be blinded to any part of the study.

CONDITIONS

Official Title

Test-retest Evaluation of [18F]F-AraG PET

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 18 years with histologically confirmed NSCLC
  • Candidate for immunotherapy as monotherapy or combination therapy for advanced or metastatic disease
  • Measurable disease
  • ECOG performance status of 0, 1, or 2
Not Eligible

You will not qualify if you...

  • Serious comorbidities that could compromise study objectives
  • Pregnant women or nursing mothers
  • Patients with severe claustrophobia

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States, 52246

Actively Recruiting

Loading map...

Research Team

A

Amy Mundisev

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here